Physician profile
Daniel Hashimoto
NPI 1346687506
$72,566.77
in general payments reported to CMS, 2019-2025
8 companies · $32K in 2025
The $32K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $5,800 · 2021: $3,049 · 2022: $9,824 · 2023: $2,638 · 2024: $1,696 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $14K · Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,720.00 |
| Travel and Lodging | $14,137.78 |
| Food and Beverage | $1,669.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $31,231.03 | 2023-2025 | Ligasure, Signia, Gi Genius |
| Medical Device Business Services, INC. | $23,444.95 | 2019-2022 | |
| Ethicon INC. | $4,922.00 | 2019-2022 | |
| Intuitive Surgical, INC. | $4,104.89 | 2019-2025 | Da Vinci Surgical System |
| US Endoscopy | $4,000.25 | 2021-2022 | |
| Activ Surgical, INC. | $2,111.10 | 2022 | |
| Boston Scientific Corporation | $1,448.80 | 2022-2025 | Apollo Esg System, Spyglass Discover, Overstitch Endoscopic Suturing System |
| Steris Corporation | $1,303.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hashimoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.